Durvalumab and Vicineum in Subjects With High-Grade Non-Muscle-Invasive Bladder Cancer Previously Treated With Bacillus Calmette-Guerin (BCG)
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
University of Texas Southwestern Medical Center
University of Pittsburgh
First Affiliated Hospital of Zhejiang University
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Superior University
NYU Langone Health
Chinese University of Hong Kong
Fondazione del Piemonte per l'Oncologia
Imperial College London
Case Comprehensive Cancer Center
Oslo University Hospital
Norfolk and Norwich University Hospitals NHS Foundation Trust
Radboud University Medical Center
Saint Louis VA Medical Center
Wake Forest University Health Sciences
Masaryk Memorial Cancer Institute
Case Comprehensive Cancer Center
Guy's and St Thomas' NHS Foundation Trust
Aarhus University Hospital
University of Roma La Sapienza
University of California, San Francisco
University of California, San Francisco
Turku University Hospital
Radboud University Medical Center
Saskatchewan Health Authority - Regina Area
Dana-Farber Cancer Institute
National Institutes of Health Clinical Center (CC)
University Health Network, Toronto
Washington University School of Medicine
University of California, Irvine
The Christie NHS Foundation Trust
Case Comprehensive Cancer Center
University of Oulu
University Health Network, Toronto
Gustave Roussy, Cancer Campus, Grand Paris
Sheba Medical Center